- Home
- MCR vs SOPH Comparison
MCR vs SOPH Comparison
Compare MCR & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCR
- SOPH
- Stock Information
- Founded
- MCR 1989
- SOPH 2011
- Country
- MCR United States
- SOPH Switzerland
- Employees
- MCR N/A
- SOPH N/A
- Industry
- MCR Trusts Except Educational Religious and Charitable
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MCR Finance
- SOPH Health Care
- Exchange
- MCR Nasdaq
- SOPH Nasdaq
- Market Cap
- MCR 263.1M
- SOPH 231.8M
- IPO Year
- MCR N/A
- SOPH 2021
- Fundamental
- Price
- MCR $6.35
- SOPH $4.39
- Analyst Decision
- MCR
- SOPH
- Analyst Count
- MCR 0
- SOPH 0
- Target Price
- MCR N/A
- SOPH N/A
- AVG Volume (30 Days)
- MCR 66.7K
- SOPH 143.2K
- Earning Date
- MCR 01-01-0001
- SOPH 11-04-2025
- Dividend Yield
- MCR 8.52%
- SOPH N/A
- EPS Growth
- MCR N/A
- SOPH N/A
- EPS
- MCR 0.38
- SOPH N/A
- Revenue
- MCR N/A
- SOPH $73,297,000.00
- Revenue This Year
- MCR N/A
- SOPH $16.60
- Revenue Next Year
- MCR N/A
- SOPH $19.09
- P/E Ratio
- MCR $16.61
- SOPH N/A
- Revenue Growth
- MCR N/A
- SOPH 13.66
- 52 Week Low
- MCR $5.63
- SOPH $2.58
- 52 Week High
- MCR $6.70
- SOPH $5.30
- Technical
- Relative Strength Index (RSI)
- MCR 45.49
- SOPH 50.24
- Support Level
- MCR $6.28
- SOPH $4.47
- Resistance Level
- MCR $6.38
- SOPH $5.11
- Average True Range (ATR)
- MCR 0.07
- SOPH 0.37
- MACD
- MCR 0.00
- SOPH -0.02
- Stochastic Oscillator
- MCR 30.00
- SOPH 41.29
About MCR MFS Charter Income Trust
MFS Charter Income Trust is a United States-based closed-end fund. Its investment objective is to seek high current income, but may also consider capital appreciation. The fund invests the assets in Debt Instruments, Corporate Bonds, U.S. Government Securities, Foreign Government Securities, Securitized Instruments, Derivatives, Principal Risks, Debt Management Risk, Investment Selection Risk, Interest Rate Risk, Credit Risk, Foreign Risks, Emerging Markets Risk, Currency Risk, Leveraging Risk, Operational and Cybersecurity Risk, Active and Frequent Trading, and etc of different market countries.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.